| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040072904 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents |
| 04/15/2004 | US20040072821 N-substituted glycine derivatives |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/14/2004 | EP1407768A2 The potassium channel opener retigabine for the treatment of diseases |
| 04/14/2004 | EP1407013A1 Mutations in ion channels |
| 04/14/2004 | EP1406926A2 Novel neurotrophic factors |
| 04/14/2004 | EP1406922A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/14/2004 | EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 04/14/2004 | EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406867A2 Thiolalkyl benzoic acid derivatives |
| 04/14/2004 | EP1406859A1 Substituted 4-aminocyclohexanol derivatives |
| 04/14/2004 | EP1406858A1 Substituted 4-aminocyclohexanols |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406660A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406637A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406605A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 04/14/2004 | EP1406495A1 Method for reducing muscle fatigue through administration of adenosine triphosphate |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | CN1489591A Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1145615C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6719805 Devices and methods for treating tissue |
| 04/08/2004 | WO2004029056A1 [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004001069A3 Compositions and methods for detecting pathologies affecting neuromuscular transmission |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | US20040068118 Conjugated aromatic compounds with a pyridine substituent |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067956 Treatment of motor fluctuations |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | CA2500228A1 [1,2,4]-triazolo[1,5-c]pyrimidine derivative |
| 04/07/2004 | EP1405637A1 Remedies for amyotrophic lateral sclerosis (als) |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404320A2 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 04/07/2004 | EP1404318A2 Compounds and methods for regulating cell differentiation |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1226133B1 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
| 04/07/2004 | EP1185272B1 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts for the treatment of bipolar disorders and mania |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716860 Azo amino acids derivatives |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | CA2084222C Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004009123A3 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/01/2004 | WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003067221A3 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/01/2004 | WO2003049675A3 Treating muscle wasting with selective androgen receptor modulators |
| 04/01/2004 | WO2003031940A3 Structural and cytoskeleton-associated proteins |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | WO2002066480A3 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 04/01/2004 | US20040063946 Jnk inhibitor |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063757 Urotensin-ll receptor antagonists |
| 04/01/2004 | US20040063752 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX-2) inhibitor(s) |
| 04/01/2004 | US20040063751 Such as N-(2-cyclohexyloxynitrophenyl)methane sulfonamide |
| 04/01/2004 | US20040063748 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |